Isolation of Chlamydia psittaci ovis in sheep thyroid cell culture

1979 ◽  
Vol 104 (3) ◽  
pp. 55-56 ◽  
Author(s):  
G. Robinson ◽  
I. Anderson
1985 ◽  
Vol 147 (2) ◽  
pp. 263-272 ◽  
Author(s):  
Heloisa PASSAREIRO ◽  
Pierre P. ROGER ◽  
Francoise LAMY ◽  
Raymond LECOCQ ◽  
Jacques E. DUMONT ◽  
...  

Biochimie ◽  
1979 ◽  
Vol 61 (8) ◽  
pp. 923-930 ◽  
Author(s):  
Guy Fayet ◽  
Sonia Hovsepian

1981 ◽  
Vol 9 (4) ◽  
pp. 305-305
Author(s):  
ANN MURPHY ◽  
CARMEL MOTHERSILL ◽  
M. K. O'CONNOR ◽  
J. F. MALONE ◽  
J. K. TAAFFE

2005 ◽  
Vol 25 (7) ◽  
pp. 2846-2852 ◽  
Author(s):  
Jens Behrends ◽  
Serge Clément ◽  
Bernard Pajak ◽  
Viviane Pohl ◽  
Carine Maenhaut ◽  
...  

ABSTRACT Rhophilin 2 is a Rho GTPase binding protein initially isolated by differential screening of a chronically thyrotropin (TSH)-stimulated dog thyroid cDNA library. In thyroid cell culture, expression of rhophilin 2 mRNA and protein is enhanced following TSH stimulation of the cyclic AMP (cAMP) transduction cascade. Yeast two-hybrid screening and coimmunoprecipitation have revealed that the GTP-bound form of RhoB and components of the cytoskeleton are protein partners of rhophilin 2. These results led us to suggest that rhophilin 2 could play an important role downstream of RhoB in the control of endocytosis during the thyroid secretory process which follows stimulation of the TSH/cAMP pathway. To validate this hypothesis, we generated rhophilin 2-deficient mice and analyzed their thyroid structure and function. Mice lacking rhophilin 2 develop normally, have normal life spans, and are fertile. They have no visible goiter and no obvious clinical signs of hyper- or hypothyroidism. The morphology of thyroid cells and follicles in these mice were normal, as were the different biological tests performed to investigate thyroid function. Our results indicate that rhophilin 2 does not play an essential role in thyroid physiology.


1997 ◽  
pp. 429-432 ◽  
Author(s):  
TH Jones ◽  
RL Kennedy ◽  
SK Justice ◽  
R Davies

Interleukin-6 (IL-6) is a cytokine released by thyrocytes and is involved in disease processes such as autoimmune thyroid disease. The secretion of IL-6 can be stimulated by interleukin-1 (IL-1), tumour necrosis factor-alpha (TNF), serum, TSH and agents which increase intracellular cyclic AMP levels. Antithyroid drugs such as methimazole inhibit IL-6 production by thyrocytes but the effects of glucocorticoids and oestrogen have not been investigated. The effects of dexamethasone and 17 beta-oestradiol on IL-1-, TNF-, TSH-, forskolin- and phorbol 12-myristate 13-acetate (PMA)-stimulated IL-6 release in serum-free conditions were studied in human thyrocytes derived from patients with Graves' disease and toxic multinodular goitres, and in the immortalised human thyrocyte cell line, HTori3. Dexamethasone inhibited IL-6 production under stimulated conditions. In serum-free conditions, no basal release of IL-6 was assayable. In all but one of the primary thyroid cultures, TSH did not stimulate IL-6 release above the lower detectable limit of the assay. In Graves' and multinodular goitre thyrocytes, inhibition of IL-1 (100 U/ml)-stimulated IL-6 release by dexamethasone (100 nmol/l) was 62.51% +/- 10.43 (S.E.M.), and in HTori3 cells it was 78.35% +/- 3.9. The degree of IL-1 stimulation of IL-6 release and inhibition by dexamethasone was not significantly different in thyrocytes derived from either Graves' or multinodular glands. 17 beta-Oestradiol had no effect on IL-1-stimulated IL-6 release in either primary thyroid cell culture or in HTori3 cells.


1994 ◽  
Vol 21 (1) ◽  
pp. 41 ◽  
Author(s):  
NA White ◽  
P Timms

Clinical signs are useful in determining the level of overt disease. However, neither the complement fixation test, nor the presence of clinical signs of disease are appropriate measures for the detection of Chlamydia psittaci in koalas because of false negative rates of 43 and 57%, respectively. Infection due to C. psittaci was most accurately determined in a population of koalas in rural south-east Queensland by in vitro cell culture of samples from ocular and urogenital sites. Prevalence of infection ranged from 39 to 61% with no evidence of a trend with time. Females had more urogenital and fewer concurrent ocular and urogenital infections than males. Parous females (n = 17) were free of disease and only one was recorded with urogenital infection (cell culture). In non-parous females (n = 16), 6 showed clinical signs of urogenital disease and a further 3 were infected (cell culture).


Sign in / Sign up

Export Citation Format

Share Document